1. Home
  2. BBW vs TRML Comparison

BBW vs TRML Comparison

Compare BBW & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBW
  • TRML
  • Stock Information
  • Founded
  • BBW 1997
  • TRML 2021
  • Country
  • BBW United States
  • TRML United States
  • Employees
  • BBW N/A
  • TRML N/A
  • Industry
  • BBW Recreational Games/Products/Toys
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBW Consumer Discretionary
  • TRML Health Care
  • Exchange
  • BBW Nasdaq
  • TRML Nasdaq
  • Market Cap
  • BBW 517.9M
  • TRML 419.1M
  • IPO Year
  • BBW 2004
  • TRML N/A
  • Fundamental
  • Price
  • BBW $36.28
  • TRML $25.36
  • Analyst Decision
  • BBW Strong Buy
  • TRML Strong Buy
  • Analyst Count
  • BBW 3
  • TRML 3
  • Target Price
  • BBW $39.67
  • TRML $65.00
  • AVG Volume (30 Days)
  • BBW 198.2K
  • TRML 166.5K
  • Earning Date
  • BBW 11-29-2024
  • TRML 11-07-2024
  • Dividend Yield
  • BBW 2.21%
  • TRML N/A
  • EPS Growth
  • BBW 2.42
  • TRML N/A
  • EPS
  • BBW 3.56
  • TRML N/A
  • Revenue
  • BBW $483,367,000.00
  • TRML N/A
  • Revenue This Year
  • BBW $2.56
  • TRML N/A
  • Revenue Next Year
  • BBW $2.52
  • TRML N/A
  • P/E Ratio
  • BBW $10.20
  • TRML N/A
  • Revenue Growth
  • BBW 0.94
  • TRML N/A
  • 52 Week Low
  • BBW $21.24
  • TRML $12.12
  • 52 Week High
  • BBW $40.13
  • TRML $48.31
  • Technical
  • Relative Strength Index (RSI)
  • BBW 47.68
  • TRML 44.45
  • Support Level
  • BBW $36.75
  • TRML $25.58
  • Resistance Level
  • BBW $39.75
  • TRML $27.51
  • Average True Range (ATR)
  • BBW 1.42
  • TRML 1.75
  • MACD
  • BBW -0.38
  • TRML -0.34
  • Stochastic Oscillator
  • BBW 0.52
  • TRML 5.72

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: